Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients

American Heart Journal

Volumn 164, Issue 4, 2012, Pages 607-615

  Hess, Connie N ^a   Broderick, Samuel ^a   Piccini, Jonathan P ^a   Alexander, Karen P ^a   Newby, L Kristin ^a   Shaw, Linda K ^a   Mahaffey, Kenneth W ^a   Alexander, John H ^a   Peterson, Eric D ^a   Granger, Christopher B ^a   Lopes, Renato D ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

ACUTE CORONARY SYNDROME; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; FEMALE; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; FEMALE; FIBRINOLYTIC AGENTS; HEART FAILURE; HUMANS; HYPERTENSION; MALE; RISK ASSESSMENT; STROKE; TICLOPIDINE; TREATMENT OUTCOME; WARFARIN;

EID: 84867544441     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.07.004     Document Type: Article

References (25)

1. V. Fuster, L.E. Rydén, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e257 e354
2. V. Fuster, L.E. Ryden, and D.S. Cannom 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 123 2011 e269 e367
3. G.Y. Lip, K. Huber, and F. Andreotti Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary - a consensus document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 31 2010 1311 1318
4. K. Huber, K.J. Airaksinen, and T. Cuisset Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: similarities and dissimilarities between North America and Europe Thromb Haemost 106 2011 569 571
5. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 2007 857 867
6. S. Connolly, J. Pogue, and R. Hart Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVEW): a randomised controlled trial Lancet 367 2006 1903 1912
7. M.B. Leon, D.S. Baim, and J.J. Popma A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators N Engl J Med 339 1998 1665 1671
8. M.L. Hansen, R. Sorensen, and M.T. Clausen Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation Arch Intern Med 170 2010 1433 1441
9. B.F. Gage, A.D. Waterman, and W. Shannon Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
10. M.C. Fang, A.S. Go, and Y. Chang A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study J Am Coll Cardiol 58 2011 395 401
11. R.J. Beyth, L.M. Quinn, and C.S. Landefeld Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin Am J Med 105 1998 91 99
12. R.D. Lopes, L.E. Elliott, and H.D. White Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial Eur Heart J 30 2009 2019 2028
13. R.D. Lopes, A. Starr, and C.F. Pieper Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes Am J Med 123 2010 134 140
14. M.C. Fang, R.S. Stafford, and J.N. Ruskin National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation Arch Intern Med 164 2004 55 60
15. 2score 0-1: a nationwide cohort study Thromb Haemost 107 2012 1172 1179
16. M.B. Sellers, and L.K. Newby Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients Am Heart J 161 2011 241 246
17. E.M. Hylek, C. Evans-Molina, and C. Shea Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation Circulation 115 2007 2689 2696
18. D.A. Redelmeier, S.H. Tan, and G.L. Booth The treatment of unrelated disorders in patients with chronic medical diseases N Engl J Med 338 1998 1516 1520
19. D.P. Faxon, J.W. Eikelboom, and P.B. Berger Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting Thromb Haemost 106 2011 572 584
20. T.Y. Wang, L.A. Robinson, and F.S. Ou Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry Am Heart J 155 2008 361 368
21. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
22. C. van Walraven, R.G. Hart, and S. Connolly Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators Stroke 40 2009 1410 1416
23. M. Man-Son-Hing, and A. Laupacis Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians' fears often unfounded Arch Intern Med 163 2003 1580 1586
24. M.B. Rothberg, C. Celestin, and L.D. Fiore Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit Ann Intern Med 143 2005 241 250
25. Roldán V, Marín F, Fernández H, et al. Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a 'real world' anticoagulated atrial fibrillation population. [published online ahead of print; posted June 21, 2012]. Chest doi:10.1378/chest.12-0608.